^
Contact us  to learn more about
our Premium Content:  News alerts, weekly reports and conference planners

TEST:
AmoyDx® ROS1 Gene Fusions Detection Kit

Type:
CE Marked
Related tests:

Details

Evidence
Twitter
AmoyDx ROS1 Gene Fusions Detection Kit is an RT-PCR based nucleic acid amplifcation test which is intended for qualitative detection of 14 ROS1 gene fusions in human NSCLC FFPE (Formalin-fixed paraffin-embedded) tissue samples. Amoy Diagnostics has reached an agreement with OxOnc Development to use AmoyDx ROS1 Gene Fusions Detection Kit for a pivotal clinical trial of Pfizer's Xalkori (crizotinib) in Japan, Korea and China.
Cancer:
Non Small Cell Lung Cancer
Gene:
CD74 (CD74 Molecule), ROS1 (Proto-Oncogene Tyrosine-Protein Kinase ROS), SDC4 (Syndecan 4), SLC34A2 (Solute carrier family 34 member 2)
Drug:
Xalkori (crizotinib)
Method:
PCR